Menu
Currency
GWAS Study

Genetic variation in the HLA region is associated with susceptibility to herpes zoster.

Crosslin DR, Carrell DS, Burt A et al.

25297839 PubMed ID
GWAS Study Type
22529 Participants
176 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

CD
Crosslin DR
CD
Carrell DS
BA
Burt A
KD
Kim DS
UJ
Underwood JG
HD
Hanna DS
CB
Comstock BA
BE
Baldwin E
DA
de Andrade M
KI
Kullo IJ
TG
Tromp G
KH
Kuivaniemi H
BK
Borthwick KM
MC
McCarty CA
PP
Peissig PL
DK
Doheny KF
PE
Pugh E
KA
Kho A
PJ
Pacheco J
HM
Hayes MG
RM
Ritchie MD
VS
Verma SS
AG
Armstrong G
SS
Stallings S
DJ
Denny JC
CR
Carroll RJ
CD
Crawford DC
CP
Crane PK
MS
Mukherjee S
BE
Bottinger E
LR
Li R
KB
Keating B
MD
Mirel DB
CC
Carlson CS
HJ
Harley JB
LE
Larson EB
JG
Jarvik GP
Chapter II

Abstract

Summary of the research findings

Herpes zoster, commonly referred to as shingles, is caused by the varicella zoster virus (VZV). VZV initially manifests as chicken pox, most commonly in childhood, can remain asymptomatically latent in nerve tissues for many years and often re-emerges as shingles. Although reactivation may be related to immune suppression, aging and female sex, most inter-individual variability in re-emergence risk has not been explained to date. We performed a genome-wide association analyses in 22,981 participants (2280 shingles cases) from the electronic Medical Records and Genomics Network. Using Cox survival and logistic regression, we identified a genomic region in the combined and European ancestry groups that has an age of onset effect reaching genome-wide significance (P>1.0 × 10(-8)). This region tags the non-coding gene HCP5 (HLA Complex P5) in the major histocompatibility complex. This gene is an endogenous retrovirus and likely influences viral activity through regulatory functions. Variants in this genetic region are known to be associated with delay in development of AIDS in people infected by HIV. Our study provides further suggestion that this region may have a critical role in viral suppression and could potentially harbor a clinically actionable variant for the shingles vaccine.

2,016 European ancestry cases, 16,407 European ancestry controls, 173 African ancestry cases, 3,312 African ancestry controls, 41 Hispanic cases, 580 Hispanic controls

Chapter III

Study Statistics

Key metrics and study information

22529
Total Participants
GWAS
Study Type
No
Replicated
African unspecified, Hispanic or Latin American, European
Ancestry
U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.